ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
21 announcements
Reliance Chemotex Industries Ltd reported unaudited financial results for the quarter ended September 30, 2026. Total income reached Rs.119.63 Crore with a net profit of Rs.4.58 Crore.
Reliance Chemotex notified a Board Meeting on 05 Nov 2026 to approve unaudited results for Q1 FY27. No financial figures or decisions are yet reported.
Infina Finance Private Limited has adopted and filed its Code of Conduct and Code of Practices and Procedures for Fair Disclosure of UPSI per SEBI regulations.
Reliance Chemotex Industries Ltd has submitted its quarterly shareholding pattern for the quarter ended September 30, 2026. This is a routine compliance filing.
Reliance Chemotex Industries re-appointed Mr. Sanjiv Shroff as Executive Director for a 36-month term, effective September 1, 2026.
Reliance Chemotex Industries Ltd held its 48th Annual General Meeting on September 24, 2026, where members transacted business, including the declaration of a final dividend.
Reliance Chemotex Industries Ltd has filed the notice for its 48th Annual General Meeting, scheduled for September 24, 2026, alongside the Annual Report for FY2025-26.
Reliance Chemotex Industries Ltd. has approved the re-appointment of Mr. Sanjiv Shroff as Managing Director. His new three-year term commences on September 1, 2026.
Reliance Chemotex Industries Ltd announced September 18, 2026, as the record date for its 48th AGM and dividend payment. Book closure is scheduled from September 18-24, 2026.
Reliance Chemotex Industries Ltd reported revenue from operations of ₹98.8 Cr (+6.9% YoY) and net profit of ₹1.4 Cr (+27.3% YoY) for Q1 FY27.
Reliance Chemotex Industries scheduled a board meeting for August 11, 2026. The board will consider Q1 financial results and the 48th Annual General Meeting details.
Reliance Chemotex Industries disclosed its quarterly shareholding pattern as of June 30, 2026. Promoter and body corporate holdings are detailed per Regulation 31(1)(b).
The company reminded shareholders to update KYC details and warned of IEPF transfer for unclaimed dividends. Investors should act promptly to avoid loss of shares.
Reliance Chemotex Industries amended its Fair Disclosure Code for Unpublished Price Sensitive Information. Approved by the Board, the policy aligns with updated SEBI Insider Trading Regulations.
Reliance Chemotex Industries approved the re-appointment of its cost and internal auditors for 12-month terms. The decision ensures continuity in the company's financial oversight and compliance.
Reliance Chemotex Industries recommended a final dividend of ₹0.5 per equity share for FY 2025-26. Record and AGM dates will be finalized later.
Reliance Chemotex Industries re-appointed its Internal and Cost Auditors for the 2026-27 financial year. The Board approved these appointments to ensure continued regulatory and internal compliance.
Reliance Chemotex Industries Ltd reported revenue from operations of ₹88.2 Cr (+7.3% YoY) and net profit of ₹1.7 Cr (-5.6% YoY) for Q4 FY26.
Reliance Chemotex approved its FY26 audited results and recommended a 5% dividend. The company also transitioned to a new tax regime, providing future tax concessions.
Reliance Chemotex scheduled a board meeting on May 29, 2026, to approve FY26 results and consider a final dividend. Investors should monitor the dividend announcement.
Reliance Chemotex Industries Ltd announced the results of its postal ballot conducted via remote e-voting. Shareholders approved the re-appointment of Mr. Ram Niwas Sharma as a Non-Executive Independent Director with a 99.99% majority. The scrutinizer confirmed the process was fair and transparent.